Introduction
The characteristic features of paralysis agitans have long been familiar to doctors in many disciplines. For the most part the diagnosis poses no serious strain on the doctor's intellect or powers of observation. The typical resting tremor, cog-wheel and plastic rigidity in the neck, trunk and limbs accompanied by the important disorder of posture and the poverty and slowness of volitional movement immediately attract attention. Diagnosis is almost entirely based on clinical observation. It is frequently made within a few seconds of the patient's entry to the consulting room, and if the diagnostic impression is not formed at this stage it may escape recognition for some considerable time.
Present day practice yields a population of the idiopathic type of disease as originally described by James Parkinson in 1817, in over 90/4 of patients. Practice in a mental hospital of course discloses a much higher proportion of patients afflicted by druginduced disease, which will be discussed later. By idiopathic, we imply that the primary aetiological agent is unknown. A depletion of dopaminergic central neuro-transmission (Bernheimer et al., 1973) operating mainly at the level of the substantia nigra and its efferent pathway the corpus striatum is the fundamental biochemical basis which is probably common to all patterns of Parkinsonism. It is, however, clear that dopamine deficiency is not the sole basis of the disease, for were this so, it would be arrested or cured in every case by replacement of dopamine by various pharmacological manoeuvres. The failures and relatively short-term success of dopamine replacement are sufficiently obvious to indicate that there is much more involved than a simple deficiency of this transmitter substance.
Nevertheless, depletion of the pigmented nerve cells in the substantia nigra is an essential ingredient of both the idiopathic and the much less common symptomatic varieties of Parkinsonism. In addition to the nerve cell loss and formation of Lewy bodies in Parkinson's disease, there is also frequently found a degree of reduction of brain weight, dilatation of the ventricular system and widening of the cortical sulci. Similar changes have been found in postencephalitic varieties of disease, and are also constantly observed in the parkinsonian syndrome associated with Alzheimer's pre-senile dementia to which reference will be made later.
Physical agents
Before coming to the more commonly encountered syndromes, some rare causes of the syndrome must be mentioned. Firstly, instances of manganese poisoning and carbon monoxide poisoning figure in all the major neurological treatises. They are extremely rare in clinical practice, but both agents are known to damage nigrostriatal neurones by cytotoxic mechanisms. (Parsons, 1928 In the more severe cases the prognosis was worse than in paralysis agitans, but the fact that there is still a large number of survivors in whom the disease has apparently become stationary after the passage of many years, indicates that at least one variant of this extraordinary condition is comparatively benign. In passing, it is of interest that these patients have been unusually sensitive to dopamine replacement, and that oculogyric crises are usually unaffected by this treatment.
'Arteriosclerotic Parkinsonism'
We are all familiar with the cases of bilateral hemiplegia or patients who have sustained multiple minor strokes. The latter group are often hypertensive without major extracranial vascular disease but with a multitude of tiny lacunae which represent microinfarcts in the basal ganglia internal capsule and pons. The sliced brain in such a case in the affected region resembles Gruyere cheese. The clinical features of these patients are characteristic, and include bilateral spastic weakness of face, arms and legs, often asymmetrical with enhanced reflexes and extensor plantar responses. Explosive laughter and crying, dysphagia and a highly characteristic nasal dysarthria, and a brisk jaw-jerk constituting 'pseudobulbar palsy' complete the picture. The bilateral spastic weakness of the facial muscles produces an immobile expressionless appearance, and the involvement of pyramidal tracts in both legs produces a slow shuffling, short-stepped gait. The superficial resemblance to Parkinson's disease is thus evident. But the resemblance is only superficial and the true extra-pyramidal signs of basal ganglia disease are seldom seen (Pearce and Pearce, 1971) . It is of course true that the patients with Parkinsonism in their 70's and 80's will frequently have co-existing cerebrovascular disease, but all the current evidence suggests that they are purely coincidental. Eadie and Sutherland (1964) suggested that the incidence of arterial disease in parkinsonian patients did not differ from control subjects of similar age and sex distribution. Finally, direct pathological correlation between Parkinson- ism and discrete cerebrovascular lesions is rare.
Drug-induced Parkinsonism
Parkinsonism induced by drug therapy is now the commonest form of symptomatic disease. In 1961, Ayd found that of 3775 patients treated with drugs of the phenothiazine group, 1472 had extra-pyramidal syndromes. Of these, 21 2% showed akathisia, 15-4%y Parkinsonism, and 2-3y. dyskinesia including oculogyric crises. One can therefore expect to find parkinsonian signs in about 33%/ of all patients with long-term phenothiazine treatment. Whether the disorder can be wholly prevented by concomitant medication with anticholinergic drugs remains doubtful, but it is certain that symptoms and disability are considerably lessened by such therapy.
How long it takes to induce Parkinsonism with psychotropic drugs is clinically relevant. It has been observed between 3 and 6 weeks after treatment of tetanus with chlorpromazine. Under these circumstances of relatively brief courses of therapy the syndrome is entirely reversible when treatment is stopped. There is, however, evidence that after continued treatment for many months or years, withdrawal of the drug may, on occasion, not be followed by the remission which usually occurs within 2 or 3 weeks of its discontinuation.
Reserpine exerts its effect by displacing dopamine from nerve endings, and in this instance levodopa will reverse the iatrogenic syndrome. Phenothiazines and butyrophenones including haloperidol act by causing blockade of the dopamine receptors, and in these patients the beneficial effect of levodopa is less striking, and a better response may be obtained by anticholinergic drugs.
In all instances of apparent drug-induced Parkinsonism, the clinical problem is whether the syndrome is entirely iatrogenic or whether the patient harboured latent Parkinson's disease which has become manifest only by further dopamine antagonism caused by the drug therapy. It may be argued that drug-induced cases which do not revert to normality on withdrawal of the drug are in fact examples of latent Parkinson's disease which has become unmasked by the psychotropic agent.
Alzheimer's disease
Although dementia is the most striking ingredient of Alzheimer's disease, a variety of subtle neurological signs are almost invariably found in this syndrome. A tetrad of clinical features has been described which becomes relevant in this discussion because of the high incidence (60%.) of a Parkinsonian syndrome (Pearce, 1974 (Selby, 1967) .
The incidence of Parkinsonism in the context of dementia is of some interest, and is accompanied by histological changes in the basal ganglia in primary Alzheimer's disease (Pearce, 1974 
Conclusions
With the exception of drug-induced disease, symptomatic Parkinsonism is relatively uncommon in clinical practice. Its theoretical implications range widely as has been suggested in this somewhat sketchy survey of the field. When confronted with (i) atypical clinical signs; (ii) a syndrome whose progression is unusual; (iii) a response to treatment which does not follow the expected course, the clinician would be wise to reassess the patient and investigate further to clarify the possibility of Parkinsonism secondary to some other primary disease process.
